Trial Profile
Perineural Dexmedetomidine as an Adjuvant to Bupivacaine-induced Ultrasound-guided Femoral Nerve Block.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Dexmedetomidine (Primary) ; Bupivacaine
- Indications Perioperative pain; Postoperative pain; Procedural pain
- Focus Therapeutic Use
- 29 Oct 2013 New trial record